327 related articles for article (PubMed ID: 15640921)
21. Review of regional measles surveillance data in the Americas, 1996-99.
Hersh BS; Tambini G; Nogueira AC; Carrasco P; de Quadros CA
Lancet; 2000 Jun; 355(9219):1943-8. PubMed ID: 10859039
[TBL] [Abstract][Full Text] [Related]
22. Etiologies of rash and fever illnesses in Campinas, Brazil.
de Moraes JC; Toscano CM; de Barros EN; Kemp B; Lievano F; Jacobson S; Afonso AM; Strebel PM; Cairns KL;
J Infect Dis; 2011 Sep; 204 Suppl 2():S627-36. PubMed ID: 21954258
[TBL] [Abstract][Full Text] [Related]
23. Interruption of measles transmission in Brazil, 2000-2001.
Prevots DR; Parise MS; Segatto TC; Siqueira MM; dos Santos ED; Ganter B; Perreira MC; Domingues CA; Lanzieri T; Da Silva JB
J Infect Dis; 2003 May; 187 Suppl 1():S111-20. PubMed ID: 12721901
[TBL] [Abstract][Full Text] [Related]
24. An evaluation of measles serodiagnosis during an outbreak in a vaccinated community.
Sekla L; Stackiw W; Eibisch G; Johnson I
Clin Invest Med; 1988 Aug; 11(4):304-9. PubMed ID: 3168353
[TBL] [Abstract][Full Text] [Related]
25. The Measles Laboratory Network in the region of the Americas.
Venczel L; Rota J; Dietz V; Morris-Glasgow V; Siqueira M; Quirogz E; Rey G; de Quadros C
J Infect Dis; 2003 May; 187 Suppl 1():S140-5. PubMed ID: 12721905
[TBL] [Abstract][Full Text] [Related]
26. Global Measles and Rubella Laboratory Network, January 2004-June 2005.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2005 Nov; 54(43):1100-4. PubMed ID: 16267497
[TBL] [Abstract][Full Text] [Related]
27. [Surveillance system for adverse events following immunization against yellow fever in Burkina Faso in 2008. Good practice recommendations].
Yaméogo TM; Breugelmans JG; Kambou JL; Badolo O; Tiendrebéogo S; Traoré E; Avokey F; Yactayo S
Med Trop (Mars); 2009 Aug; 69(4):320-1. PubMed ID: 19725376
[TBL] [Abstract][Full Text] [Related]
28. Integrating measles and rubella surveillance: the experience in the Caribbean.
Irons B; Carrasco P; Morris-Glasgow V; Castillo-Solórzano C; de Quadros CA
J Infect Dis; 2003 May; 187 Suppl 1():S153-7. PubMed ID: 12721907
[TBL] [Abstract][Full Text] [Related]
29. [Measles at the point of being eliminated].
De Ory F; Peña-Rey I
Enferm Infecc Microbiol Clin; 2010 Feb; 28(2):73-4. PubMed ID: 20096973
[No Abstract] [Full Text] [Related]
30. Etiology of measles suspect cases reported in 2006-2007 in Poland.
Siennicka J; Stefanoff P; Rogalska J; Trzcińska A
Przegl Epidemiol; 2011; 65(1):39-44. PubMed ID: 21735834
[TBL] [Abstract][Full Text] [Related]
31. Laboratory investigations are indispensable to monitor the progress of measles elimination--results of the German Measles Sentinel 1999-2003.
Tischer A; Santibanez S; Siedler A; Heider A; Hengel H
J Clin Virol; 2004 Nov; 31(3):165-78. PubMed ID: 15465408
[TBL] [Abstract][Full Text] [Related]
32. Can a minimum rate of investigation of measleslike illnesses serve as a standard for evaluating measles surveillance?
Harpaz R; Papania MJ
J Infect Dis; 2004 May; 189 Suppl 1():S204-9. PubMed ID: 15106112
[TBL] [Abstract][Full Text] [Related]
33. Measles surveillance in the United States: an overview.
Guris D; Harpaz R; Redd SB; Smith NJ; Papania MJ
J Infect Dis; 2004 May; 189 Suppl 1():S177-84. PubMed ID: 15106108
[TBL] [Abstract][Full Text] [Related]
34. Rash after measles vaccination: laboratory analysis of cases reported in São Paulo, Brazil.
Oliveira MI; Curti SP; Figueiredo CA; Afonso AM; Theobaldo M; Azevedo RS; Durigon EL
Rev Saude Publica; 2002 Apr; 36(2):155-9. PubMed ID: 12045795
[TBL] [Abstract][Full Text] [Related]
35. Progress toward measles mortality reduction and elimination--Eastern Mediterranean Region, 1997-2007.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2008 Mar; 57(10):262-7. PubMed ID: 18340334
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of the adequacy of measles laboratory diagnostic tests in the era of accelerating measles elimination in Beijing, China.
Ma R; Lu L; Suo L; Zhangzhu J; Chen M; Pang X
Vaccine; 2019 Jun; 37(29):3804-3809. PubMed ID: 31153690
[TBL] [Abstract][Full Text] [Related]
37. Simultaneous IgM reactivity by EIA against more than one virus in measles, parvovirus B19 and rubella infection.
Thomas HI; Barrett E; Hesketh LM; Wynne A; Morgan-Capner P
J Clin Virol; 1999 Oct; 14(2):107-18. PubMed ID: 10588453
[TBL] [Abstract][Full Text] [Related]
38. Confirmed interruption of indigenous measles transmission in Catalonia.
Salleras L; Domínguez A; Torner N
Euro Surveill; 2001 Jul; 6(7):113-7. PubMed ID: 12631955
[TBL] [Abstract][Full Text] [Related]
39. Feasibility of global measles eradication after interruption of transmission in the Americas.
de Quadros CA; Andrus JK; Danovaro-Holliday MC; Castillo-Solórzano C
Expert Rev Vaccines; 2008 Apr; 7(3):355-62. PubMed ID: 18393605
[TBL] [Abstract][Full Text] [Related]
40. Expanded Programme on Immunization (EPI). Progress towards elimination of measles in the Americas.
Wkly Epidemiol Rec; 1998 Mar; 73(12):81-5. PubMed ID: 9557582
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
